Literature DB >> 856467

Isolation of glycoprotein antigen from ascites fluid of pancreatic carcinoma.

T M Chu, E D Holyoke, H O Douglass.   

Abstract

A glycoprotein antigen from the ascites fluid of pancreatic carcinoma has been isolated with the use of perchloric acid extraction and chromatographies on Sepharose 4B, DEAE-Sephadex, and DE52, followed by Sephadex G-200. The purified glycoprotein was found to be homogenous by sodium dodecyl sulfate polyacrylamide gel electrophoresis. A molecular weight of 185,000 dattons was determined by gel filtration. The molecule contained 55% protein and 45% carbohydrate. Both the amino acid and carbohydrate compositions were different from those of carcinoembryonic antigen. This glycoprotein antigen of pancreatic cancer cross-reacted with anticarcinoembryonic antigen; however, the antiserum prepared from this antigen did not react with carcinoembryonic antigen. The biological significance of this glycoprotein in pancreatic cancer is being studied.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856467

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  The induction of human peripheral blood lymphoid colonies by conditioned media from human tumour cell lines.

Authors:  D H Vesole; G E Moore
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

2.  A pancreatic oncofetal antigen: its partial purification and clinical application.

Authors:  T Homma; H Oguchi; S Kawa
Journal:  Gastroenterol Jpn       Date:  1981

3.  Human pancreatic secretory protein profiles in the search for tumor markers.

Authors:  T T White; B J Allan; J J Schilling; H Miyashita
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

4.  Monoclonal antibody defines CA 19-9 in pancreatic juices and sera.

Authors:  W H Schmiegel; C Kreiker; W Eberl; R Arndt; M Classen; H Greten; K Jessen; H Kalthoff; N Soehendra; H G Thiele
Journal:  Gut       Date:  1985-05       Impact factor: 23.059

5.  A study of secretory proteins, cytology and tumor site in pancreatic cancer.

Authors:  R L Goodale; R M Condie; T D Dressel; T N Taylor; K Gajl-Peczalska
Journal:  Ann Surg       Date:  1979-03       Impact factor: 12.969

6.  Reactivity of monoclonal anti-human pancreatic carcinoma antibodies AR2-20 and AR1-28 with tumors of nonpancreatic origin.

Authors:  J Chin; R Zuna; F Miller
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

7.  Enzyme-linked PNA lectin binding assay compared with CA19-9 and CEA radioimmunoassay as a diagnostic blood test for pancreatic cancer.

Authors:  C K Ching; J M Rhodes
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

8.  Immunochemical and immunohistological analyses of tumor-associated antigens defined by murine monoclonal antibodies against human pancreatic carcinoma cells.

Authors:  S Koyama; R Mukai; K Fukao; T Osuga
Journal:  Jpn J Cancer Res       Date:  1988-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.